These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8062101)
1. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Itagaki S; Akiyama H; Saito H; McGeer PL Brain Res; 1994 May; 645(1-2):78-84. PubMed ID: 8062101 [TBL] [Abstract][Full Text] [Related]
2. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378 [TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Webster S; Lue LF; Brachova L; Tenner AJ; McGeer PL; Terai K; Walker DG; Bradt B; Cooper NR; Rogers J Neurobiol Aging; 1997; 18(4):415-21. PubMed ID: 9330973 [TBL] [Abstract][Full Text] [Related]
4. Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Ikeda K; Akiyama H; Arai T; Kondo H; Haga C; Iritani S; Tsuchiya K Neurosci Lett; 1998 Dec; 258(2):113-6. PubMed ID: 9875540 [TBL] [Abstract][Full Text] [Related]
5. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
6. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803 [TBL] [Abstract][Full Text] [Related]
7. Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide. Shen Y; Sullivan T; Lee CM; Meri S; Shiosaki K; Lin CW Brain Res; 1998 Jun; 796(1-2):187-97. PubMed ID: 9689469 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Nishikawa T; Takahashi T; Nakamori M; Yamazaki Y; Kurashige T; Nagano Y; Nishida Y; Izumi Y; Matsumoto M Neuropathol Appl Neurobiol; 2014 Jun; 40(4):489-501. PubMed ID: 23631697 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains. Sihag RK; Wang LW; Cataldo AM; Hamlin M; Cohen CM; Nixon RA Brain Res; 1994 Sep; 656(1):14-26. PubMed ID: 7804827 [TBL] [Abstract][Full Text] [Related]
10. Activation of the classical complement pathway in brain tissue of Alzheimer patients. McGeer PL; Akiyama H; Itagaki S; McGeer EG Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373 [TBL] [Abstract][Full Text] [Related]
11. Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer's disease by tandem mass spectrometry. Minjarez B; Valero Rustarazo ML; Sanchez del Pino MM; González-Robles A; Sosa-Melgarejo JA; Luna-Muñoz J; Mena R; Luna-Arias JP J Alzheimers Dis; 2013; 34(1):239-62. PubMed ID: 23229080 [TBL] [Abstract][Full Text] [Related]
12. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
13. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059 [TBL] [Abstract][Full Text] [Related]
14. Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models. Carpanini SM; Torvell M; Bevan RJ; Byrne RAJ; Daskoulidou N; Saito T; Saido TC; Taylor PR; Hughes TR; Zelek WM; Morgan BP Acta Neuropathol Commun; 2022 Jul; 10(1):99. PubMed ID: 35794654 [TBL] [Abstract][Full Text] [Related]
15. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. Smith MA; Rudnicka-Nawrot M; Richey PL; Praprotnik D; Mulvihill P; Miller CA; Sayre LM; Perry G J Neurochem; 1995 Jun; 64(6):2660-6. PubMed ID: 7539057 [TBL] [Abstract][Full Text] [Related]